ABCL
Price
$2.23
Change
+$0.14 (+6.70%)
Updated
Apr 2, 02:27 PM (EDT)
Capitalization
663.02M
41 days until earnings call
BEAM
Price
$18.46
Change
+$0.82 (+4.65%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
1.95B
41 days until earnings call
Ad is loading...

ABCL vs BEAM

Header iconABCL vs BEAM Comparison
Open Charts ABCL vs BEAMBanner chart's image
AbCellera Biologics
Price$2.23
Change+$0.14 (+6.70%)
Volume$600
Capitalization663.02M
Beam Therapeutics
Price$18.46
Change+$0.82 (+4.65%)
Volume$44.78K
Capitalization1.95B
ABCL vs BEAM Comparison Chart
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. BEAM commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a StrongBuy and BEAM is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (ABCL: $2.09 vs. BEAM: $17.64)
Brand notoriety: ABCL and BEAM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 105% vs. BEAM: 228%
Market capitalization -- ABCL: $663.02M vs. BEAM: $1.95B
ABCL [@Biotechnology] is valued at $663.02M. BEAM’s [@Biotechnology] market capitalization is $1.95B. The market cap for tickers in the [@Biotechnology] industry ranges from $302.51B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileBEAM’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • BEAM’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than ABCL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 4 TA indicator(s) are bullish while BEAM’s TA Score has 4 bullish TA indicator(s).

  • ABCL’s TA Score: 4 bullish, 5 bearish.
  • BEAM’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ABCL is a better buy in the short-term than BEAM.

Price Growth

ABCL (@Biotechnology) experienced а -17.39% price change this week, while BEAM (@Biotechnology) price change was -24.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.91%. For the same industry, the average monthly price growth was -7.11%, and the average quarterly price growth was -11.65%.

Reported Earning Dates

ABCL is expected to report earnings on May 13, 2025.

BEAM is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-4.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.95B) has a higher market cap than ABCL($663M). ABCL (-28.669) and BEAM (-28.891) have similar YTD gains . ABCL has higher annual earnings (EBITDA): -204.15M vs. BEAM (-383.98M). BEAM has more cash in the bank: 851M vs. ABCL (626M). ABCL has less debt than BEAM: ABCL (65.4M) vs BEAM (161M). BEAM has higher revenues than ABCL: BEAM (63.5M) vs ABCL (28.8M).
ABCLBEAMABCL / BEAM
Capitalization663M1.95B34%
EBITDA-204.15M-383.98M53%
Gain YTD-28.669-28.89199%
P/E RatioN/AN/A-
Revenue28.8M63.5M45%
Total Cash626M851M74%
Total Debt65.4M161M41%
TECHNICAL ANALYSIS
Technical Analysis
ABCLBEAM
RSI
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 6 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 10 days ago
77%
Bullish Trend 6 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FFEIX13.91N/A
N/A
Nuveen Dividend Value A
VISGX70.80N/A
N/A
Vanguard Small Cap Growth Index Inv
LSPIX5.52N/A
N/A
LoCorr Spectrum Income I
MACEX12.81N/A
N/A
Martin Currie Emerging Markets A
NBHEX14.04N/A
N/A
Neuberger Berman Equity Income E

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with CRSP. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
-6.28%
CRSP - ABCL
57%
Loosely correlated
-2.62%
NTLA - ABCL
56%
Loosely correlated
-6.40%
VCYT - ABCL
56%
Loosely correlated
-0.30%
BEAM - ABCL
55%
Loosely correlated
-9.70%
ABSI - ABCL
53%
Loosely correlated
-4.38%
More